Michael Joyner and Nigel Paneth argue that we need fewer promises and more debate

Quick Read

DNA is the code of life, and so advances that allow us to edit that code have unlocked vast potential, from simply editing away the buggy code of disease, to engineering animals that don’t spread illness, to, maybe one day in a distant future, creating so-called designer babies. But editing another essential molecular component of our biology—RNA, the cells to turns DNA instructions into proteins—also holds great promise

Quick Read

It’s nowhere close. It was an audacious undertaking, even for one of the most storied American companies: With a single machine, IBM would tackle humanity’s most vexing diseases and revolutionize medicine.

Quick Read

The controversy over genetically modified crops has long focused on largely unsubstantiated fears that they are unsafe to eat. But an extensive examination by The New York Times indicates that the debate has missed a more basic problem — genetic modification in the United States and Canada has not accelerated increases in crop yields or led to an overall reduction in the use of chemical pesticides

Quick Read